Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Mori

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
International Journal of Hematology|June 27, 2019
Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity testTakeshi Kondo, Mari Fujioka, Shinichi Fujisawa, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 22, 2008
Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammationMasakata Yoshioka, Hironori Sagara, Fumiyuki Takahashi, et al.
Neurology|January 5, 2018
Serum caffeine and metabolites are reliable biomarkers of early Parkinson diseaseMotoki Fujimaki, Shinji Saiki, Yuanzhe Li, et al.
Annals of Clinical and Translational Neurology|February 15, 2020
Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 diseaseShin-Ichi Ueno, Taku Hatano, Ayami Okuzumi, et al.
Journal of Pharmacological Sciences|February 11, 2026
Tacrolimus attenuates Th17 cell-mediated allergic skin inflammation in miceFatemeh Beygom Mirkatouli, Yukiko Tao, Uyanga Enkhbaatar, et al.
Hematological Oncology|August 17, 2020
Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseasesKatsuya Fujimoto, Kanako C Hatanaka, Yutaka Hatanaka, et al.
Arerugi = [Allergy]|December 11, 2014
[Comparison of exhaled nitric oxide levels measured by two offline methods and the NO breath® method in Japan]Jun Ito, Takahiro Tsuburai, Ryo Atsuta, et al.
Neurobiology of Aging|June 30, 2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's diseaseTaku Hatano, Manabu Funayama, Shin-Ichiro Kubo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2020
Shared Metabolic Profile of Caffeine in Parkinsonian DisordersHaruka Takeshige-Amano, Shinji Saiki, Motoki Fujimaki, et al.
International Journal of Hematology|January 31, 2025
Chronic graft-versus-host disease myelitis successfully treated with rituximabEmi Yokoyama, Yuta Hasegawa, Kentaro Wakaki, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
International Journal of Hematology|June 27, 2019
Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity testTakeshi Kondo, Mari Fujioka, Shinichi Fujisawa, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 22, 2008
Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammationMasakata Yoshioka, Hironori Sagara, Fumiyuki Takahashi, et al.
Neurology|January 5, 2018
Serum caffeine and metabolites are reliable biomarkers of early Parkinson diseaseMotoki Fujimaki, Shinji Saiki, Yuanzhe Li, et al.
Annals of Clinical and Translational Neurology|February 15, 2020
Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 diseaseShin-Ichi Ueno, Taku Hatano, Ayami Okuzumi, et al.
Journal of Pharmacological Sciences|February 11, 2026
Tacrolimus attenuates Th17 cell-mediated allergic skin inflammation in miceFatemeh Beygom Mirkatouli, Yukiko Tao, Uyanga Enkhbaatar, et al.
Hematological Oncology|August 17, 2020
Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseasesKatsuya Fujimoto, Kanako C Hatanaka, Yutaka Hatanaka, et al.
Arerugi = [Allergy]|December 11, 2014
[Comparison of exhaled nitric oxide levels measured by two offline methods and the NO breath® method in Japan]Jun Ito, Takahiro Tsuburai, Ryo Atsuta, et al.
Neurobiology of Aging|June 30, 2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's diseaseTaku Hatano, Manabu Funayama, Shin-Ichiro Kubo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2020
Shared Metabolic Profile of Caffeine in Parkinsonian DisordersHaruka Takeshige-Amano, Shinji Saiki, Motoki Fujimaki, et al.
International Journal of Hematology|January 31, 2025
Chronic graft-versus-host disease myelitis successfully treated with rituximabEmi Yokoyama, Yuta Hasegawa, Kentaro Wakaki, et al.
Pageof 24